SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Novo Nordisk A/S (NOVOB.CO) News

Track canonical SquawkNews coverage tagged to NOVOB.CO, Novo Nordisk A/S. This hub brings together deduplicated headlines about yhd, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol NOVOB.CO Asset equity Sector Markets 90 days 1 Updated Sep 18, 2026, 06:42 AM UTC Open live news feed
H BUZZ — Sandoz seen rising after it secures Canada approval for generic GLP — 1 shot * Shares in Sandoz are indicated to rise 3% pre-market after Swiss generic drugmaker received regulatory approval for its generic semaglutide to treat type-2 diabetes in Canada * The injection is a generic version of Nov EQUITY | Sep 18, 2026, 06:42 AM UTC